High Triglyceride-Glucose Index is Associated with Poor Cardiovascular Outcomes in Nondiabetic Patients with ACS with

Yue Zhang1, Xiaosong Ding1, Bing Hua1

  • 1Department of Cardiology, Cardiovascular Center, Beijing Friendship Hospital, Capital Medical University.

Insights

A high triglyceride-glucose (TyG) index predicts increased risk of acute myocardial infarction (AMI) and larger infarct size in non-diabetic acute coronary syndrome (ACS) patients. It also indicates a higher likelihood of needing revascularization.

Area of Science:

  • Cardiology
  • Metabolic Syndrome
  • Biomarkers

Background:

  • The triglyceride-glucose (TyG) index is a marker of insulin resistance.
  • Nondiabetic patients with acute coronary syndrome (ACS) and low low-density lipoprotein cholesterol (LDL-C) present unique challenges in risk stratification.
  • Identifying reliable prognostic markers in this population is crucial for optimizing patient management.

Purpose of the Study:

  • To investigate the prognostic significance of the TyG index in nondiabetic patients with ACS and LDL-C levels below 1.8 mmol/L.
  • To determine if the TyG index can predict adverse cardiovascular events, including acute myocardial infarction (AMI) and the need for revascularization.

Main Methods:

  • A cohort of 1655 nondiabetic ACS patients with LDL-C < 1.8 mmol/L was analyzed.
  • Patients were categorized into two groups based on TyG index levels (≥8.33 vs. <8.33).
  • Outcomes including incidence of AMI, infarct size, and major adverse cardiac and cerebral events were compared over a median follow-up of 35.6 months.

Main Results:

  • Patients with a higher TyG index (≥8.33) exhibited a significantly higher incidence of AMI (21.2% vs. 15.2%) and larger infarct size, indicated by elevated peak troponin I, creatine kinase-MB, and myoglobin levels.
  • While mortality did not differ significantly, the incidence of revascularization was notably higher in the high TyG index group (8.9% vs. 5.0%).
  • Multivariable Cox regression confirmed a positive association between the TyG index and revascularization (Hazard Ratio: 1.67, 95% CI: 1.02-2.75).

Conclusions:

  • In nondiabetic ACS patients with controlled LDL-C, an elevated TyG index is linked to increased AMI incidence and severity.
  • A high TyG index may serve as a valuable predictor for subsequent revascularization procedures in this patient cohort.
Abstract

Related Concept Videos

Blood Studies for Cardiovascular System III: Serum Lipid Profile01:25

Blood Studies for Cardiovascular System III: Serum Lipid Profile

Understanding serum lipids is crucial for maintaining cardiovascular health and preventing heart disease and stroke.
Serum lipids are fats and fatty substances in the blood and are crucial for various bodily functions, including energy storage, cellular structure, and hormone production. Serum lipids consist of cholesterol, triglycerides, and phospholipids.
Cholesterol is a soft, fat-like substance found in all body cells. It is crucial for producing hormones, vitamin D, and substances that aid...
428
Coronary Artery Disease I: Introduction01:30

Coronary Artery Disease I: Introduction

Coronary Artery Disease (CAD): An Overview with Scientific InsightsCoronary Artery Disease (CAD), often referred to as C-A-D, is a prevalent blood vessel disorder classified under the broader category of atherosclerosis. Atherosclerosis is a pathological process characterized by the hardening and narrowing of arteries due to the accumulation of atherosclerotic plaques. These plaques are composed of cholesterol, fatty substances, inflammatory cells, calcium, and fibrin, reducing blood flow to...
663
Atherosclerosis III: Management01:26

Atherosclerosis III: Management

Management of atherosclerosis involves an integrated strategy encompassing pharmacological treatment, surgical interventions, lifestyle changes, and nutrition therapy to address the multifactorial nature of the disease.Pharmacological TherapyA cornerstone of atherosclerosis management is the use of pharmacological agents. Statins, such as atorvastatin, are pivotal in inhibiting HMG-CoA reductase, an enzyme that catalyzes an initial step in cholesterol synthesis in the liver. This reduction in...
113
Coronary Artery Disease IV: Preventive Measures01:26

Coronary Artery Disease IV: Preventive Measures

Effective preventive measures for coronary artery disease (CAD) focus on controlling modifiable risk factors, including cholesterol abnormalities and lifestyle changes.Cholesterol ManagementFirst, the Mediterranean diet and the American Heart Association advocate for maintaining low-density lipoprotein (LDL) cholesterol levels below 100 mg/dL, with a more stringent recommendation of below 70 mg/dL for individuals at high risk. LDL cholesterol, often termed "bad cholesterol," can lead to the...
475
Lipids: Dietary Sources and Requirements01:18

Lipids: Dietary Sources and Requirements

Lipids are an essential component of a balanced human diet. Triglycerides, which make up the majority of dietary lipids, are found in both saturated fats—commonly present in meat, dairy products, and certain tropical plants like coconut, and hydrogenated oils such as margarine and baking shortenings (trans fats)—and unsaturated fats, which are abundant in seeds, nuts, olive oil, and most vegetable oils. The main sources of cholesterol include egg yolks, various meats and organ...
1.5K
Overview of Lipid Metabolism01:24

Overview of Lipid Metabolism

Lipid metabolism is a crucial process in the human body that involves the synthesis and degradation of lipids. This process is essential for energy production, cell membrane formation, and hormone production, among other functions.
Lipolysis: The Breakdown of Lipids:
Lipolysis is the process of breaking down lipids, particularly triglycerides, into glycerol and fatty acids. This process typically occurs in the adipose tissue and is triggered by various hormones, including glucagon and...
3.8K